Melissa Foster

The emergence of new treatments and therapeutic approaches for psoriatic arthritis is improving physicians’ ability to treat a complicated, multifaceted disease.

Artificial intelligence is not yet a routine fixture in medicine, but it may soon change how physicians approach medical care, including prediction and diagnosis of diabetes complications.

Earlier diagnosis of certain types of age-related macular degeneration is integral to preserve vision for patients.

The benefits of type 1 diabetes screening have long been up for debate, but FDA approval of the first therapy to delay the disease’s onset may be changing the conversation.

A few months ago, I would have questioned the value of universal screening for type 1 diabetes because we did not have anything to offer people who are at risk for the disease. However, we now have a drug — teplizumab-mzwv — that can delay the onset of type 1 diabetes. That is an important advance.

A nutritional program that focused on increased intake of prebiotics and probiotics improved cardiometabolic health in patients with schizophrenia spectrum disorders, according to a study published in BMC Psychiatry.

Telehealth interventions were as effective as in-person treatment for reducing anxiety and depressive symptoms, according to data published in BMC Psychiatry.

New data suggest a link between consumption of theobromine, a primary ingredient in chocolate, and an increased risk for depression.

Exposure to antipsychotics during pregnancy may not increase risk for birth defects, according to a study published in JAMA Psychiatry.

A multidiagnostic prediction model developed using deep learning was highly predictive of mental disorder diagnosis, according to new data published in JAMA Psychiatry.